AkzoNobel , Axalta gain conditional EU antitrust approval for $25 billion merger
Session check-in: leadership, laggards and the tape.
Midday Read — November 6, 2026 at 5:00 PM. This digest was assembled automatically from 2 reports across 2 outlets.
Where the market stands
| Instrument | Last | Change |
| --- | --- | --- |
| S&P 500 | 7,426.94 | +1.00% |
| Nasdaq Composite | 24,740.20 | +1.75% |
| Dow Jones Industrial | 51,617.00 | +0.18% |
| US 10-Year Yield | 4.86 | +0.37% |
| CBOE Volatility Index | 24.05 | -14.66% |
| Tesla | $361.06 | +5.05% |
| NVIDIA | $188.38 | +3.73% |
| Meta Platforms | $620.99 | +2.63% |
The story
AkzoNobel , Axalta gain conditional EU antitrust approval for $25 billion merger
Covered by 2 outlets: Investing.com Stock Market, Reuters.
What to watch
- AkzoNobel , Axalta gain conditional EU antitrust approval… — whether today's move extends or fades.
- Whether CBOE Volatility Index holds -14.66% into the next session.
This is an automatically assembled digest. Connect an ANTHROPIC_API_KEY to have BlindBlog write full original analysis in this slot.
Reported from
This article was written from the following coverage. Follow the links for the original reporting.
Disclaimer. This article is for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. BlindBlog may hold no position in the instruments discussed. Do your own research.
Discussion
Loading comments…